Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CRIS, Curis (formerly CBMI) -- Ignore unavailable to you. Want to Upgrade?

To: SemiBull who wrote (451)	4/7/2003 7:30:23 PM
From: SemiBull	Read Replies (1) \| Respond to of 668

9:23AM Curis drug candidate identified as treatment for skin cancer (CRIS) 0.83: Announces that the current online issue of The Proceedings of the National Academy of Sciences reports that CURIS scientists have identified a novel small molecule drug candidate, CUR-61414, for the treatment of basal cell carcinoma, a skin cancer and the most common form of all human cancers with approx 1 mln new cases every year in the U.S. finance.yahoo.com